Share Price:

APNASPENAspen Pharmacare Hldgs9862-209 (-2.08%)

Divestment of Aspenโ€™s European Thrombosis Business to Mylan and withdrawal of cautionary

Johannesburg – Following the release of a cautionary announcement on 24 August 2020, Aspen is pleased to announce that, Aspen Global Incorporated (โ€œAGIโ€), its wholly owned subsidiary incorporated in Mauritius, has concluded an agreement in terms of which Mylan Ireland Limited (โ€œMylanโ€) will acquire the commercialisation rights and related intellectual property relating to Aspenโ€™s Thrombosis… Continue reading Divestment of Aspenโ€™s European Thrombosis Business to Mylan and withdrawal of cautionary

Closed Period

Aspen is in a closed period from 1 January until the publication of our interim results on the JSE SENS platform scheduled to be released on 1 March 2023.

The live presentation will take place in Cape Town at 08h30 on 2 March 2023.